Literature DB >> 21885991

Signaling mechanisms mediating uridine adenosine tetraphosphate-induced proliferation of human vascular smooth muscle cells.

Yu Gui1, Gordon He, Michael P Walsh, Xi-Long Zheng.   

Abstract

Proliferation of vascular smooth muscle cells (SMCs) plays an important role in the development of atherosclerosis and restenosis. Extracellular mononucleotides, such as adenosine triphosphate and uridine-5'-triphosphate stimulate SMC proliferation. However, the effects of dinucleotides on SMC proliferation and their underlying signaling mechanisms are less well defined. Recently, increasing evidence suggests that the dinucleotide, uridine adenosine tetraphosphate (Up4A) plays a role in the regulation of cardiovascular function. We have previously demonstrated that Up4A stimulates DNA synthesis and proliferation of human SMCs. This study investigated the signaling mechanisms underlying the proliferative effect of Up4A. Up4A-induced increase in bromodeoxyuridine incorporation was blocked by the mammalian target of rapamycin inhibitor, rapamycin, and the MEK inhibitor, PD98059. Up4A-stimulated phosphorylation and kinase activity of S6 kinase (S6K) and Erk1/2 were inhibited by PD98059, whereas phosphorylation and kinase activity of S6K, but not Erk1/2, were inhibited by rapamycin. Up4A also increased the phosphorylation of Akt, which was blocked by the PI3-kinase inhibitor, LY294002. Up4A-stimulated activation of S6K, but not Erk1/2, was also prevented by LY294002. Furthermore, Up4A-stimulated phosphorylation and kinase activity of S6K and Erk1/2 were inhibited by the P2 receptor antagonist, suramin, but not by the P2X receptor antagonist, Ip5I. Up4A also stimulated an increase in the protein expression of cycle-dependent kinase 2, which was prevented by rapamycin, PD98059, and suramin. These results suggest that the signaling mechanisms underlying the Up4A-stimulated proliferation of SMCs are mediated by P2Y receptors and involve the PI3-K/Akt and mitogen-activated protein kinase pathways, leading to the independent activation of S6K and an increase in cycle-dependent kinase 2 expression. This work stresses the concept that dinucleotides, like mononucleotides, play potentially important roles in the regulation of vascular function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21885991     DOI: 10.1097/FJC.0b013e318231e929

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  7 in total

Review 1.  Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes.

Authors:  Takayuki Matsumoto; Styliani Goulopoulou; Kumiko Taguchi; Rita C Tostes; Tsuneo Kobayashi
Journal:  Br J Pharmacol       Date:  2015-07-08       Impact factor: 8.739

Review 2.  Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update.

Authors:  Zhichao Zhou; Takayuki Matsumoto; Vera Jankowski; John Pernow; S Jamal Mustafa; Dirk J Duncker; Daphne Merkus
Journal:  Pharmacol Res       Date:  2018-12-13       Impact factor: 7.658

3.  Enhanced uridine adenosine tetraphosphate-induced contraction in renal artery from type 2 diabetic Goto-Kakizaki rats due to activated cyclooxygenase/thromboxane receptor axis.

Authors:  Takayuki Matsumoto; Shun Watanabe; Ryusuke Kawamura; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Pflugers Arch       Date:  2013-07-31       Impact factor: 3.657

4.  P2X1 receptor-mediated inhibition of the proliferation of human coronary smooth muscle cells involving the transcription factor NR4A1.

Authors:  Annette Viktoria Hinze; Peter Mayer; Anja Harst; Ivar von Kügelgen
Journal:  Purinergic Signal       Date:  2013-07-20       Impact factor: 3.765

5.  The enzymatic activity of the VEGFR2 receptor for the biosynthesis of dinucleoside polyphosphates.

Authors:  Vera Jankowski; Anna Schulz; Axel Kretschmer; Harald Mischak; Falko Boehringer; Markus van der Giet; Doreen Janke; Mirjam Schuchardt; Ralf Herwig; Walter Zidek; Joachim Jankowski
Journal:  J Mol Med (Berl)       Date:  2013-05-01       Impact factor: 4.599

6.  The role of uridine adenosine tetraphosphate in the vascular system.

Authors:  Takayuki Matsumoto; Rita C Tostes; R Clinton Webb
Journal:  Adv Pharmacol Sci       Date:  2011-11-01

7.  Alteration of Vascular Responsiveness to Uridine Adenosine Tetraphosphate in Aortas Isolated from Male Diabetic Otsuka Long-Evans Tokushima Fatty Rats: The Involvement of Prostanoids.

Authors:  Takayuki Matsumoto; Shota Kobayashi; Makoto Ando; Maika Iguchi; Keisuke Takayanagi; Mihoka Kojima; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Int J Mol Sci       Date:  2017-11-09       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.